BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14089817)

  • 1. THE USE OF SERUM CREATINE PHOSPHOKINASE AND OTHER SERUM ENZYMES IN THE DIAGNOSIS OF PROGRESSIVE MUSCULAR DYSTROPHY.
    SWAIMAN KF; SANDLER B
    J Pediatr; 1963 Dec; 63():1116-9. PubMed ID: 14089817
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. I. SERUM ENZYMES IN PROGRESSIVE MUSCULAR DYSTROPHY (TYPE I, II, IIIA)].
    ROTTHAUWE HW; KOWALEWSKI S
    Klin Wochenschr; 1965 Feb; 43():144-50. PubMed ID: 14258511
    [No Abstract]   [Full Text] [Related]  

  • 3. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. I. MUSCULAR DYSTROPHY.
    FOWLER WM
    Arch Phys Med Rehabil; 1964 Mar; 45():117-24. PubMed ID: 14127953
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. 3. RECESSIVE X-CHROMOSOMAL MUSCULAR DYSTROPHY WITH RELATIVELY BENIGN COURSE].
    ROTTHAUWE HW; KOWALEWSKI S
    Klin Wochenschr; 1965 Feb; 43():158-63. PubMed ID: 14258512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 6. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. II. NEUROLOGIC DISEASES OTHER THAN MUSCULAR DYSTROPHY.
    FOWLER WM; PEARSON CM
    Arch Phys Med Rehabil; 1964 Mar; 45():125-30. PubMed ID: 14127954
    [No Abstract]   [Full Text] [Related]  

  • 7. [MUSCULAR DYSTROPHY OF THE DUCHENNE TYPE: ENZYMATIC ACTIVITY IN A FAMILIAL GROUP OF SUBJECTS WITH AND WITHOUT CLINICAL MANIFESTATIONS].
    MARZUOLI U; RUBINO R; BOCCALATTE G
    Minerva Med; 1965 Jan; 56():90-2. PubMed ID: 14248694
    [No Abstract]   [Full Text] [Related]  

  • 8. CREATINE PHOSPHOKINASE AND OTHER SERUM ENZYME ACTIVITY AFTER CONTROLLED EXERCISE.
    SWAIMAN KF; AWAD EA
    Neurology; 1964 Nov; 14():977-80. PubMed ID: 14239090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 10. [DIAGNOSTIC SIGNIFICANCE OF THE SERUM ALDOLASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN CHILDHOOD].
    WILUTZKY H
    Monatsschr Kinderheilkd (1902); 1964 Aug; 112():366-9. PubMed ID: 14259613
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum enzyme alterations in neuromuscular disorders.
    Munsat TL; Baloh R; Pearson CM; Fowler W
    JAMA; 1973 Dec; 226(13):1536-43. PubMed ID: 4800933
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities.
    Morse RP; Rosman NP
    J Pediatr; 1993 Feb; 122(2):254-6. PubMed ID: 8429443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

  • 15. USE OF ENZYMES IN CARDIAC DIAGNOSIS.
    COODLEY EL
    Angiology; 1965 Apr; 16():209-25. PubMed ID: 14275867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of physical factors influencing the behaviour in vitro of serum creatine phosphokinase and other enzymes.
    Thomson WH
    Clin Chim Acta; 1969 Jan; 23(1):105-20. PubMed ID: 5762120
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE BEHAVIOR OF SERUM ALDOLASE AND TRANSAMINASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER ANABOLIC AND RE-METABOLIZING THERAPY].
    BUSCAINO GA; SEPE O
    Acta Neurol (Napoli); 1964; 19():523-46. PubMed ID: 14208396
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution on the study of pseudohypertrophic muscular dystrophies. I. Benign pseudohypertrophic muscular dystrophy].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):92-115. PubMed ID: 5800957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.